SecBot SecBot
8-K ·Filed Feb 26, 2026

UHS

UNIVERSAL HEALTH SERVICES INC
BULLISH
Impact 8/10
Horizonweeks Processed8mo ago SEC0001193125-26-073545
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The combination of strong operational performance, optimistic guidance, and resolution of a major litigation overhang presents a compelling investment case. The stock may re-rate higher on improved sentiment, though investors should monitor Medicaid reimbursement risks mentioned in the forward-looking statements.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$203.26
T+0 close · Feb 26, 2026 · via day close
Latest settled
−20.08%
T+60 · $162.45
Vs SPY
−27.83%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Feb 26 $203.26entry
  2. T+1 · 9mo ago +0.71%α +1.16% · $204.70
  3. T+5 · 9mo ago −3.17%α −2.05% · $196.81
  4. T+20 · 8mo ago −8.95%α −2.55% · $185.07
  5. T+60 · 6mo ago −20.08%α −27.83% · $162.45
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Universal Health Services reported strong 2025 financial results with 9.7% revenue growth and a 37.3% increase in adjusted EPS to $21.74, driven by volume and pricing improvements across both acute and behavioral health segments. The company also announced a favorable court ruling vacating a $500 million punitive damages verdict, though it maintains an $18 million reserve for the matter. Management provided optimistic 2026 guidance, forecasting 7.1% revenue growth and 8.5% adjusted EPS growth.

Key Financial Metrics

Revenue
$17.4B
+9.7% YoY
Adj. EPS
$21.74
GAAP: $23.10
Guidance
$18.417 billion-$18.789 billion
raised

Key Facts

  • 2025 revenue grew 9.7% to $17.365 billion; adjusted EPS increased 30.9% to $21.74
  • 2026 guidance calls for $18.417-$18.789 billion revenue (7.1% midpoint growth) and $22.64-$24.52 EPS (8.5% midpoint growth)
  • Nevada court vacated $500 million punitive damages verdict, though $18 million legal reserve remains
  • Behavioral health same-facility revenue grew 7.7%, acute care grew 8.5% in 2025
  • Company repurchased $899.3 million of stock in 2025 with $1.425 billion remaining authorization

Financial Impact

2025 revenue $17.365 billion (+9.7% YoY), adjusted EPS $21.74 (+30.9% YoY); 2026 revenue guidance $18.6 billion midpoint (+7.1% YoY), EPS guidance $23.58 midpoint (+8.5% YoY)

revenueepsguidancedilution

Segment Breakdown

SegmentRevenueGrowth
Acute Care$9.9B+8.5%
Behavioral Health$7.4B+8.0%

Risk Factors

  • Potential reinstatement of punitive damages on appeal (though capped at $14 million under Nevada law)
  • Legislative changes limiting Medicaid enrollment and provider fees could impact future revenues
  • Interest rate increases have adversely impacted free cash flow

Market Snapshot

Exchange
NYSE

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-073545
Document: uhs-20260225.htm0001193125-26-073545
Document: 0001193125-26-073545-index-headers.html0001193125-26-073545
Document: 0001193125-26-073545-index.html0001193125-26-073545
Document: 0001193125-26-073545.txt0001193125-26-073545

Track record

12 reports on UHS

Performance horizon

0 of 3 bullish or bearish reports moved the stock their way by T+1. Best: −0.63% at T+1 after the Oct 23, 2026 report. 0 of 3 went positive at some point.

Filters
  1. Oct 27, 202620d ago 8-K Bearish 6/10 No price data
  2. Oct 27, 202620d ago Press Release Bearish 5/10 Entry $172.18 to $176.61 Now $197.80 −14.88% ▼ −2.57% −2.95% vs SPY
  3. Oct 23, 202624d ago Institutional Cluster Bullish 4/10 Entry $186.89 to $185.71 Now $197.80 +5.84% ▼ −0.63% −1.34% vs SPY
  4. Oct 19, 202628d ago SC 13G Neutral 3/10 Entry $182.29 to $185.61 Now $197.80 +8.51% ▲ +1.82% +1.49% vs SPY
  5. Oct 8, 20265w ago SC 13G Neutral 3/10 Entry $175.72 to $177.35 Now $197.80 +12.57% ▲ +0.93% +0.33% vs SPY
  6. Oct 5, 20266w ago Press Release Neutral 1/10 Entry $177.08 Now $197.80 +11.70% No price data
  7. Aug 21, 202612w ago 8-K Neutral 4/10 Entry $177.26 to $176.40 Now $197.80 +11.59% ▼ −0.49% −0.19% vs SPY
  8. Jul 27, 202616w ago Press Release Bearish 6/10 Entry $166.22 to $168.16 Now $197.80 −19.00% ▼ −1.17% −2.71% vs SPY
  9. May 21, 202625w ago 8-K Neutral 3/10 Entry $162.28 to $157.52 Now $197.80 +21.89% ▼ −2.93% −3.38% vs SPY
  10. Apr 24, 202629w ago 8-K Neutral 5/10 Entry $173.78 to $179.02 Now $197.80 +13.82% ▲ +3.02% +2.85% vs SPY
Showing 10 of 12

US Market Status

Market Closed · Opens in 7h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Feb 26, 2026